DRI vs PTGX · P/E 22, rev $13.21B vs rev $269.8M
Darden Restaurants Inc (DRI) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2026-05-31 was $13.21B. Net income was $1.21B. Revenue was up 9.4% from 2025-05-25 to 2026-05-31. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the DRI and PTGX stock pages for the full models.
Not investment advice.